… (A to E) The ability of the indicated mAbs to neutralize Wuhan-Hu-1, B.1.351, and B.1.351–Δ242-243
pseudovirus infectivity in 293T-hACE2 cells was measured as indicated. The …

Antibody responses develop following SARS-CoV-2 infection, but little is known about their
epitope specificities, clonality, binding affinities, epitopes, and neutralizing activity. We …

SARS-CoV-2 is a betacoronavirus virus responsible for the COVID-19 pandemic. Here, we
determine the X-ray crystal structure of a potent neutralizing monoclonal antibody, CV30, …

SARS-CoV-2 is one of three coronaviruses that have crossed the animal-to-human barrier
and caused widespread disease in the past two decades. The development of a universal …

… Another macrophage phenotype consists of anti-inflammatory macrophages that are induced
by compounds and mediators such as corticosteroids, IL-10, or prostaglandin E 2 PGE 2 . …

The respiratory tract is an attractive target organ for novel diagnostic and therapeutic
applications with nano-sized carriers, but their immune effects and interactions with key resident …

The respiratory tract is in constant contact with inhaled antigens from the external environment.
In order to shape its line of defense, it is populated by various types of immune cells. …

B cells specific for the SARS-CoV-2 S envelope glycoprotein spike were isolated from a
COVID-19-infected subject using a stabilized spike-derived ectodomain (S2P) twenty-one days …

Aluminum salts, developed almost a century ago, remain the most commonly used adjuvant
for licensed human vaccines. Compared to more recently developed vaccine adjuvants, …

The emergence of SARS-CoV-2 variants raises concerns about their resistance to neutralizing
antibodies elicited from previous infection, or from vaccination. Here we examined …